1
/
of
0
FDA Drug Approval, N207987, ABLYSINOL
FDA Drug Approval, N207987, ABLYSINOL
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 207987
Company: BPI LABS
Drug Name: ABLYSINOL
Active Ingredients: ALCOHOL
Strength: SOLUTION;INTRA-ARTERIAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD; Orphan
Company: BPI LABS
Drug Name: ABLYSINOL
Active Ingredients: ALCOHOL
Strength: SOLUTION;INTRA-ARTERIAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD; Orphan
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details